Skip to main content
HeartCited

Quercetin per Atherosclerosis

D Ricerca Esiste solo ricerca preliminare (studi di laboratorio, segnalazioni di casi).

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dquercetin\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

In sintesi

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

Key Study Findings

Other
Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating …
Dose: None vs: Allergic rhinitis mouse model vs control Outcome: Rhinitis symptoms and serum inflammatory indicators Effetto: None None

Popolazione: Allergic rhinitis mouse model

Other
Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes …
Dose: None vs: None Outcome: Inflammatory markers Effetto: None None

Popolazione: None

Review
Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease.
Dose: None vs: None Outcome: Gut microbiota composition Effetto: None None

Popolazione: None

In Vitro
Dietary Polyphenols in the Prevention of Stroke.
Dose: None vs: None Outcome: Stroke prevention Effetto: None None

Popolazione: General population (CVD risk)

Key Statistics

2

Studi

100

Partecipanti

Positive

D

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
500-1,000 mg/day
bloodpressuresupport:
500-730 mg/day

Limite massimo: Not formally established; up to 1,000 mg/day used in clinical trials

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Momento migliore per l'assunzione: With meals; vitamin C co-supplementation may enhance bioavailability

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated
  • Headache (rare)
  • Mild gastrointestinal discomfort
  • Tingling in extremities (rare, high doses)

Interazioni note

  • Antibiotics (quinolones — may reduce efficacy)
  • Cyclosporine (may increase blood levels)
  • Anticoagulants (may have mild antiplatelet effect)
  • Blood pressure medications (additive effect)

Livello di assunzione massimo tollerabile: Not formally established; up to 1,000 mg/day used in clinical trials

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Quercetin help with Atherosclerosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Quercetin may support Atherosclerosis management. Our evidence grade is D (Very Early Research).
How much Quercetin should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Quercetin?
Reported side effects may include Generally well-tolerated, Headache (rare), Mild gastrointestinal discomfort, Tingling in extremities (rare, high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Quercetin and Atherosclerosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

References

  1. [1] Sihong Huang et al.. Curr Comput Aided Drug Des. 2025. Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … doi:10.2174/0115734099299714240516160158 PubMed
  2. [2] Masoumeh Shamsi et al.. Iran J Pharm Res. 2024. Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin … doi:10.5812/ijpr-151428 PubMed
  3. [3] Wang Anlu et al.. Pharmacol Res. 2019. Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease. doi:10.1016/j.phrs.2019.02.018 PubMed
  4. [4] A Tressera-Rimbau et al.. Oxid Med Cell Longev. 2017. Dietary Polyphenols in the Prevention of Stroke. doi:10.1155/2017/7467962 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.